Publications2022-06-08T23:56:40+00:00

PUBLICATIONS

99mTc-HFAPi SPECT imaging predicts left ventricular remodeling after acute myocardial infarction

Cuncun Hua, Xiao-Ying Xi, Yeping Zhang, Ni Suo, Bin Tu, Ye Liu, Xiaoyan Yang, Xiaoyan Liu, Pixiong Su, Boqia Xie, Minfu Yang, Yanjiang Wang Abstract: Background: Despite improved treatments for acute myocardial infarction (AMI), myocardial fibrosis remains a key driver of adverse left ventricular (LV) [...]

August 4th, 2024|Publications|

Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Lukas Kessler, Felix Schwaning, Martin Metzenmacher, Kim Pabst, Jens Siveke, Marija Trajkovic-Arsic, Benedikt Schaarschmidt, Marcel Wiesweg, Clemens Aigner, Till Plönes, Kaid Darwiche, Servet Bölükbas, Martin Stuschke, Lale Umutlu, Michael Nader, Dirk Theegarten, Rainer Hamacher, Wilfried E E Eberhardt, Martin Schuler, Ken Herrmann, Wolfgang P [...]

August 1st, 2024|Publications|

The Role of Fibroblast Activation Protein Inhibitor Positron Emission Tomography in Inflammatory and Infectious Diseases: An Updated Systematic Review

Domenico Albano, Alessio Rizzo, Riemer H J A Slart, Søren Hess, Edel Noriega-Álvarez, Cristina Gamila Wakfie-Corieh, Lucia Leccisotti, Andor W J M Glaudemans, Olivier Gheysens, Giorgio Treglia Abstract: The role of fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography (PET/CT) is emerging for [...]

May 31st, 2024|Publications|

[68Ga]Ga-FAPI-46 PET/CT for penile cancer – a feasibility study

Lennert Eismann, Stephan T Ledderose, Benazir Enzinger, Elena Berg, Thilo Westhofen, Severin Rodler, Gerald B Schulz, Johannes Toms, Adrien Holzgreve, Franz J Gildehaus, Matthias Brendel, Clemens C Cyran, Marcus Unterrainer, Christian G Stief, Peter Bartenstein, Boris Schlenker, Lena M Unterrainer Purpose: Penile cancer is a [...]

May 18th, 2024|Publications|

68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy

Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, Mélanie Desaulniers, Marc Ingenwerth, Nader Hirmas, Lukas Kessler, Michael Nader, Timo Bartel, Stephan Leyser, Francesco Barbato, Martin Schuler, Sebastian Bauer, Jens T Siveke, Ken Herrmann, Rainer Hamacher, Wolfgang P Fendler Abstract: Fibroblast activation protein-α (FAP) is [...]

May 9th, 2024|Publications|

A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers

Marinus J Hagens, Pim J van Leeuwen, Maurits Wondergem, Thierry N Boellaard, Francesco Sanguedolce, Daniela E Oprea-Lager, Axel Bex, André N Vis, Henk G van der Poel, Laura S Mertens; EAU Section of Urological Imaging Abstract: In contemporary oncologic diagnostics, molecular imaging modalities are [...]

April 18th, 2024|Publications|

Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE”

David Kersting, Silvia Morbelli, Sophie E. M. Veldhuijzen van Zanten & Hein J. Verberne Introduction: Between the 9th and 13th of September 2023, the international nuclear medicine community gathered in Vienna, hometown to the headquarters of the European Association of Nuclear Medicine (EANM), for [...]

April 4th, 2024|Publications|

Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor

Rainer Hamacher, Kim M Pabst, Phyllis F Cheung, Christoph E Heilig, Jennifer Hüllein, Sven-Thorsten Liffers, Sabrina Borchert, Pedro Fragoso Costa, Benedikt M Schaarschmidt, Lukas Kessler, Monika A Miera, Margret Droste, Merve Akbulut, Johanna Falkenhorst, Fadi Zarrad, Karina Kostbade, Ilektra A Mavroeidi, Hanno Glimm, Lale [...]

February 18th, 2024|Publications|

18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma

Xiang Li, Na Lu, Lili Lin, Yiwen Chen, Shuye Yang, Huatao Wang, Xinyuan Liu, Chengyi Wu, Xing Xue, Xinhui Su, Xueli Bai, Tingbo Liang Abstract Accurate diagnosis and staging are crucial for selecting treatment for patients with pancreatic ductal adenocarcinoma (PDAC). The desmoplastic responses [...]

February 12th, 2024|Publications|

68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study

Ling Chen, Shan Zheng, Linying Chen, Sunwang Xu, Kunlin Wu, Lingjun Kong, Jiajie Xue, Xiangjin Chen, Weibing Miao, Youzhi Zhu Abstract 68Ga-labeled fibroblast activation protein inhibitor (68Ga-FAPI) PET/CT has demonstrated promising clinical results, with a higher SUVmax and tumor-to-background ratio (TBR) in breast cancer [...]

December 1st, 2023|Publications|

CONTACT US

Are you a pharmaceutical company or distribution network interested obtaining FAPI for your projects and patients? We are eager to learn more about how our compounds can facilitate your needs.

Go to Top